Terms: = Lung cancer AND WT1, WAGR, 7490, ENSG00000184937, WT33, GUD, WIT-2
251 results:
1. Dendritic cell vaccination in combination with erlotinib in a patient with inoperable lung adenocarcinoma: a case report.
Kosumi T; Kobayashi M; Shimodaira S; Sugiyama H; Koido S
J Med Case Rep; 2024 Feb; 18(1):88. PubMed ID: 38336778
[TBL] [Abstract] [Full Text] [Related]
2. BAP1, Wilms' tumor 1, and calretinin in predicting survival and response to first-line chemotherapy in patients with pleural mesothelioma.
Yuce TH; Ak G; Metintas S; Dundar E; Roe OD; Panou V; Metintas M
J Cancer Res Clin Oncol; 2024 Jan; 150(2):38. PubMed ID: 38280040
[TBL] [Abstract] [Full Text] [Related]
3. Expanding the molecular landscape of undifferentiated sarcomas of bone with a novel EWSR1-SSX3 gene fusion.
Fumagalli C; Orellana R; Ferré M; Gonzalez A; Catasús L; Vázquez T; Sebio A; López-Pousa A; Llauger J; Peiró A; Antonescu CR
Genes Chromosomes Cancer; 2024 Jan; 63(1):e23215. PubMed ID: 38050902
[TBL] [Abstract] [Full Text] [Related]
4. Cytomorphologic and immunocytochemical characterization of pediatric pleuropulmonary blastoma with a comprehensive review of the literature.
Gupta P; Chugh S; Gupta N; Gupta K; Sodhi KS; Kakkar N; Srinivasan R; Rohilla M; Kundu R; Trehan A; Bansal D; Peters NJ
Diagn Cytopathol; 2024 Feb; 52(2):103-115. PubMed ID: 37964698
[TBL] [Abstract] [Full Text] [Related]
5. Desmoplastic small round cell tumor of the abdomen: A case report.
Li R; Liu W; Ye L
Medicine (Baltimore); 2023 Nov; 102(45):e35965. PubMed ID: 37960784
[TBL] [Abstract] [Full Text] [Related]
6. Wilms' tumour gene 1 (wt1) enhances non-small cell lung cancer malignancy and is inhibited by microRNA-498-5p.
Li X; An W; Pan H; Fan Y; Huang H; Wang Y; Shen W; Zu L; Meng F; Zhou X
BMC Cancer; 2023 Sep; 23(1):824. PubMed ID: 37667197
[TBL] [Abstract] [Full Text] [Related]
7. [Analysis of clinicopathological features of 68 cases of malignant pleural mesothelioma].
Mei W; Yang SJ; Zhang YP; Fu QS; Xiong W; Zhao Y
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2023 Aug; 41(8):588-593. PubMed ID: 37667154
[No Abstract] [Full Text] [Related]
8. TP53 mutation prevalence in normal airway epithelium as a biomarker for lung cancer risk.
Craig DJ; Crawford EL; Chen H; Grogan EL; Deppen SA; Morrison T; Antic SL; Massion PP; Willey JC
BMC Cancer; 2023 Aug; 23(1):783. PubMed ID: 37612638
[TBL] [Abstract] [Full Text] [Related]
9. SARS-CoV-2 infection perturbs enhancer mediated transcriptional regulation of key pathways.
Yedidya Y; Davis D; Drier Y
PLoS Comput Biol; 2023 Aug; 19(8):e1011397. PubMed ID: 37561814
[TBL] [Abstract] [Full Text] [Related]
10. Comparison of immunohistochemical mesothelial biomarkers in paired biopsies and effusion cytology cell blocks from pleural mesothelioma.
Mansour MSI; Huseinzade A; Seidal T; Hejny K; Maty A; Taheri-Eilagh F; Mager U; Dejmek A; Dobra K; Brunnström H
Cytopathology; 2023 Sep; 34(5):456-465. PubMed ID: 37337638
[TBL] [Abstract] [Full Text] [Related]
11. Traditional Treatment Approaches and Role of Immunotherapy in lung Malignancy and Mesothelioma.
Tamanna MT; Egbune C
Cancer Treat Res; 2023; 185():79-89. PubMed ID: 37306905
[TBL] [Abstract] [Full Text] [Related]
12. Recurrent Tumor Suppressor Alterations in Primary Pericardial Mesothelioma.
Schaefer IM; Mariño-Enríquez A; Hammer MM; Padera RF; Sholl LM
Mod Pathol; 2023 Sep; 36(9):100237. PubMed ID: 37295554
[TBL] [Abstract] [Full Text] [Related]
13. Circular non-coding RNA circ_0072088 serves as a ceRNA, targeting the miR-1225-5p/wt1 axis to regulate non-small cell lung cancer cell malignant behavior.
Zhu X; Wan J; You X; Yang W; Zhao L
Thorac Cancer; 2023 Jul; 14(20):1969-1979. PubMed ID: 37220935
[TBL] [Abstract] [Full Text] [Related]
14. Diffuse intrapulmonary mesothelioma mimicking pulmonary lepidic adenocarcinoma: a rare case report and review of the literature.
RanYue W; ChunYan W; Likun H; LiPing Z; JieLu L; ZhengWei D
Diagn Pathol; 2023 May; 18(1):64. PubMed ID: 37194050
[TBL] [Abstract] [Full Text] [Related]
15. [Cytopathological characterization of ascites for the diagnosis of serous ovarian carcinoma].
Chang YH; Zou BQ; Cai Y; Yang SD; Zhang Y; Liang JB; Li C
Zhonghua Zhong Liu Za Zhi; 2023 May; 45(5):424-432. PubMed ID: 37188628
[No Abstract] [Full Text] [Related]
16. Surgical phenotype of patients with peritoneal mesothelioma and a germline mutation.
Berger Y; Gadiraju M; Dhiman A; Gilliam K; Opalecky B; Chen H; Helgeson M; Eng OS; Husain AN; Drazer MW; Kindler HL; Churpek JE; Turaga KK
Cancer; 2023 Jul; 129(14):2152-2160. PubMed ID: 37042570
[TBL] [Abstract] [Full Text] [Related]
17. [Mucinous tubular and spindle cell carcinoma of kidney: Clinicopathology and prognosis].
Shen Q; Liu YX; He Q
Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Apr; 55(2):276-282. PubMed ID: 37042138
[TBL] [Abstract] [Full Text] [Related]
18. Establishment of an experimental model of canine malignant mesothelioma organoid culture using a three-dimensional culture method.
Sato Y; Elbadawy M; Suzuki K; Tsunedomi R; Nagano H; Ishihara Y; Yamamoto H; Azakami D; Uchide T; Nabeta R; Fukushima R; Abugomaa A; Kaneda M; Yamawaki H; Shinohara Y; Usui T; Sasaki K
Biomed Pharmacother; 2023 Jun; 162():114651. PubMed ID: 37030135
[TBL] [Abstract] [Full Text] [Related]
19. Highlighting the immunohistochemical differences of malignant mesothelioma subtypes via case presentations.
Sejben A; Pancsa T; Tiszlavicz L; Furák J; Paróczai D; Zombori T
Thorac Cancer; 2023 Apr; 14(10):857-863. PubMed ID: 36808895
[TBL] [Abstract] [Full Text] [Related]
20. Outcomes Following Treatment with FOLFOX for Patients with Resectable or Potentially Resectable Metastatic Colorectal cancer: A Population-based Cohort Study.
Habbous S; Tai X; Gill T; Arias J; Beca J; Raphael MJ; Kennedy E; Biagi JJ; Chan KKW
Clin Oncol (R Coll Radiol); 2023 Mar; 35(3):188-198. PubMed ID: 36610878
[TBL] [Abstract] [Full Text] [Related]
[Next]
